These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33694178)

  • 1. Reduced rank multinomial logistic regression in Markov chains with application to cognitive data.
    Wang P; Abner EL; Fardo DW; Schmitt FA; Jicha GA; Van Eldik LJ; Kryscio RJ
    Stat Med; 2021 May; 40(11):2650-2664. PubMed ID: 33694178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ignoring baseline on modeling transitions from intact cognition to dementia.
    Yu L; Tyas SL; Snowdon DA; Kryscio RJ
    Comput Stat Data Anal; 2009 Jul; 53(9):3334-3343. PubMed ID: 20161282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonstationary Markov transition model for computing the relative risk of dementia before death.
    Yu L; Griffith WS; Tyas SL; Snowdon DA; Kryscio RJ
    Stat Med; 2010 Mar; 29(6):639-48. PubMed ID: 20087848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-Markov models for interval censored transient cognitive states with back transitions and a competing risk.
    Wei S; Kryscio RJ
    Stat Methods Med Res; 2016 Dec; 25(6):2909-2924. PubMed ID: 24821001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia.
    Salazar JC; Schmitt FA; Yu L; Mendiondo MM; Kryscio RJ
    Stat Med; 2007 Feb; 26(3):568-80. PubMed ID: 16345024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.
    Tyas SL; Salazar JC; Snowdon DA; Desrosiers MF; Riley KP; Mendiondo MS; Kryscio RJ
    Am J Epidemiol; 2007 Jun; 165(11):1231-8. PubMed ID: 17431012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic transitions in mild cognitive impairment by use of simple Markov models.
    Facal D; Guàrdia-Olmos J; Juncos-Rabadán O
    Int J Geriatr Psychiatry; 2015 Jul; 30(7):669-76. PubMed ID: 25315251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markov Transition Model to Dementia with Death as a Competing Event.
    Wei S; Xu L; Kryscio RJ
    Comput Stat Data Anal; 2014 Dec; 80():78-88. PubMed ID: 25110380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-state Markov model in outcome of mild cognitive impairments among community elderly residents in Mainland China.
    Yu HM; Yang SS; Gao JW; Zhou LY; Liang RF; Qu CY
    Int Psychogeriatr; 2013 May; 25(5):797-804. PubMed ID: 23286508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covariate adjustment of event histories estimated from Markov chains: the additive approach.
    Aalen OO; Borgan O; Fekjaer H
    Biometrics; 2001 Dec; 57(4):993-1001. PubMed ID: 11764270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic transitions in mild cognitive impairment subtypes.
    Forlenza OV; Diniz BS; Nunes PV; Memória CM; Yassuda MS; Gattaz WF
    Int Psychogeriatr; 2009 Dec; 21(6):1088-95. PubMed ID: 19691909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-homogeneous continuous-time Markov chain with covariates: Applications to ambulatory hypertension monitoring.
    Chang J; Chan HK; Lin J; Chan W
    Stat Med; 2023 May; 42(12):1965-1980. PubMed ID: 36896833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Landmark estimation of transition probabilities in non-Markov multi-state models with covariates.
    Hoff R; Putter H; Mehlum IS; Gran JM
    Lifetime Data Anal; 2019 Oct; 25(4):660-680. PubMed ID: 30997582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for transitions from normal to mild cognitive impairment and dementia.
    Kryscio RJ; Schmitt FA; Salazar JC; Mendiondo MS; Markesbery WR
    Neurology; 2006 Mar; 66(6):828-32. PubMed ID: 16567698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-homogeneous Markov process models with informative observations with an application to Alzheimer's disease.
    Chen B; Zhou XH
    Biom J; 2011 May; 53(3):444-63. PubMed ID: 21491475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of non-monotonic transition rates in a semi-Markov process with covariates adjustments and application to caregivers' stress data.
    Ngan E; Chan W; Leon-Novelo L; Pavlik V
    Stat Med; 2023 Dec; 42(30):5646-5656. PubMed ID: 37807023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients.
    Bizzotto R; Zamuner S; De Nicolao G; Karlsson MO; Gomeni R
    J Pharmacokinet Pharmacodyn; 2010 Apr; 37(2):137-55. PubMed ID: 20052524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.